J.D. Power data shows a mixed bag, with some models scoring well and others falling far behind.
Median overall survival of 15.8 months in Cyclin E1-positive platinum-resistant ovarian cancer patients indicates promising efficacy of azenosertib monotherapy. The data will be presented at a major ...
October 25 (Sun), 2026A new week begins.There are times when you need the courage to move forward, and times when it is ...
Aldeman: Let students work independently, at their own pace, using high-quality content, guided by teachers and assessed with ...
Data to be presented as a rapid oral presentation at ESMO Congress 2026 on October 23, 2026 SAN DIEGO, Oct. 18, 2026 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical ...
Clear communication, practical follow-ups and steady effort may help you make progress without extra pressure. | Horoscope ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results